Stockreport

Cara Therapeutics launches late-stage study of CR845 in CKD-aP [Seeking Alpha]

Cara Therapeutics, Inc.  (CARA) 
Last cara therapeutics, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.caratherapeutics.com/investor-relations
PDF Cara Therapeutics launches late-stage study of CR845 in CKD-aPCara Therapeutics (NASDAQ:CARA)initiates a Phase 3 clinical trial assessing lead candidate IV CR845, brande [Read more]